2024-06 |
Reference Standards for C-Peptide in Korean Population: A Korean Endocrine Hormone Reference Standard Data Center Study |
Endocrinology and Metabolism
|
2024-04 |
DA-6034 ameliorates hepatic steatosis and inflammation in high fat diet-induced obese mice |
Journal of Yeungnam Medical Science
|
2024-02 |
Resting heart rate is associated with the prevalence of chronic kidney disease in Korean adult: the Korean National Health and Nutrition Survey |
BMC public health
|
2024-01 |
DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis |
DIABETES & METABOLISM JOURNAL
|
2023-12 |
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism |
Endocrinology and Metabolism
|
2023-11 |
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension |
DIABETES & METABOLISM JOURNAL
|
2023-09 |
Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study |
Diabetes, Obesity and Metabolism
|
2023-07 |
Glomerular filtration barrier modeling on a chip with tunable basement membrane deposition and 3D cultured podocytes |
LAB ON A CHIP
|
2023-07 |
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis |
Diabetes and Metabolism Journal
|
2023-07 |
Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial |
DIABETES OBESITY & METABOLISM
|
2023-06 |
Hyperglycemia-activated 11β-hydroxysteroid dehydrogenase type 1 increases endoplasmic reticulum stress and skin barrier dysfunction |
Scientific Reports
|
2023-05 |
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial |
Diabetes, Obesity and Metabolism
|
2023-04 |
Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice |
Yonsei Medical Journal
|
2022-11 |
Analysis of clinical phenotypes of neuropathic symptoms in patients with type 2 diabetes: A multicenter study |
JOURNAL OF DIABETES INVESTIGATION
|
2022-11 |
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus |
DIABETES & METABOLISM JOURNAL
|
2022-10 |
Missed Ipsilateral Adrenal Adenoma With Recurrent Hypercortisolism After Prior Left Adrenalectomy |
Journal of Korean Medical Science
|
2022-05 |
Curcumin Blocks High Glucose-Induced Podocyte Injury via RIPK3-Dependent Pathway |
Frontiers in Cell and Developmental Biology
|
2022-05 |
Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
|
2022-05 |
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain |
CLINICAL JOURNAL OF PAIN
|
2022-02 |
EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation |
Endocrinology and Metabolism
|
2021-10 |
Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea |
Endocrinology and Metabolism
|
2021-09 |
Dehydrozingerone inhibits renal lipotoxicity in high-fat diet-induced obese mice |
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
|
2021-08 |
Tetrahydrocurcumin Ameliorates Kidney Injury and High Systolic Blood Pressure in High-Fat Diet-Induced Type 2 Diabetic Mice |
Endocrinology and Metabolism
|
2021-06 |
Tetrahydrocurcumin Ameliorates Skin Inflammation by Modulating Autophagy in High-Fat Diet-Induced Obese Mice |
BIOMED RESEARCH INTERNATIONAL
|
2021-04 |
Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy |
PLOS ONE
|
2021-01 |
RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death |
Cells
|
2020-12 |
APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice |
FREE RADICAL BIOLOGY AND MEDICINE
|
2020-10 |
Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial |
CLINICAL THERAPEUTICS
|
2020-09 |
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study) |
DIABETES OBESITY & METABOLISM
|
2020-05 |
The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2 |
FEBS JOURNAL
|
2020-05 |
A Novel non-PPARgamma Insulin Sensitizer: MLR-1023 Clinicalproof-Of-Concept in Type 2 Diabetes Mellitus |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
2020-02 |
Curcumin analog CUR5–8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity |
METABOLISM-CLINICAL AND EXPERIMENTAL
|
2019-09 |
CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress |
PLOS ONE
|
2019-09 |
Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line |
Endocrinology and Metabolism
|
2019-07 |
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial |
LANCET DIABETES & ENDOCRINOLOGY
|
2019-05 |
Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease |
SCIENTIFIC REPORTS
|
2019-05 |
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial |
LANCET
|
2019-02 |
Dibenzoylmethane ameliorates lipid-induced inflammation and oxidative injury in diabetic nephropathy |
JOURNAL OF ENDOCRINOLOGY
|
2019-01 |
Exposure to pesticides and the prevalence of diabetes in a rural population in Korea |
NEUROTOXICOLOGY
|
2018-11 |
Caffeic acid ameliorates hepatic steatosis and decreased endoplasmic reticulum stress in high-fat diet-induced obese mice by regulating autophagy |
NUTRITION
|
2018-10 |
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial |
LANCET
|
2018-10 |
Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial |
DIABETES OBESITY & METABOLISM
|
2018-08 |
Impaired permeability and antimicrobial barriers in type 2 diabetes skin are linked to increased serum levels of advanced glycation end-product |
EXPERIMENTAL DERMATOLOGY
|
2018-06 |
A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone |
DIABETES OBESITY & METABOLISM
|
2018-06 |
Effect of a short-term physical activity intervention on liver fat content in obese children |
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
|
2018-05 |
Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model |
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
|
2018-03 |
An Unusual Case of Meningioma Showing Increased CaSR Expression with Parathyroid Carcinoma |
대한내분비학회지
|
2018-03 |
Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model |
EUROPEAN JOURNAL OF NUTRITION
|
2018-02 |
Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status |
OBESITY
|
2018-02 |
iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner |
INTERNATIONAL JOURNAL OF OBESITY
|
2017-12 |
Characteristics of Korean Patients with Primary Adrenal Insufficiency: A Registry-Based Nationwide Survey in Korea |
대한내분비학회지
|
2017-12 |
Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise |
DIABETES OBESITY & METABOLISM
|
2017-10 |
Effects of lobeglitazone, a novel thiazolidinedione, on bone mineral density in patients with type 2 diabetes mellitus over 52 weeks |
Diabetes and Metabolism Journal
|
2017-09 |
Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial |
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
|
2017-08 |
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes |
NEW ENGLAND JOURNAL OF MEDICINE
|
2017-07 |
Combined effect of initial and longitudinal increases in γ-glutamyltransferase on incident metabolic syndrome: ARIRANG study |
YONSEI MEDICAL JOURNAL
|
2017-06 |
α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2 |
PLOS ONE
|
2017-06 |
Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice |
PLOS ONE
|
2017-05 |
Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study) |
DIABETES OBESITY & METABOLISM
|
2017-05 |
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension |
DIABETES OBESITY & METABOLISM
|
2017-04 |
Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus |
JOURNAL OF DIABETES
|
2017-02 |
Relationship between regional body fat distribution and diabetes mellitus: 2008 to 2010 Korean national health and nutrition examination surveys |
Diabetes and Metabolism Journal
|
2017-01 |
Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status |
METABOLISM-CLINICAL AND EXPERIMENTAL
|
2016-10 |
Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial |
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
|
2016-07 |
Decreased plasma alpha-Klotho predict progression of nephropathy with type 2 diabetic patients |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
2016-06 |
High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus A Longitudinal Population-Based Study |
MEDICINE
|
2016-05 |
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial |
DIABETES OBESITY & METABOLISM
|
2016-05 |
Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy |
YONSEI MEDICAL JOURNAL
|
2016-05 |
Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial |
JOURNAL OF DIABETES
|
2016-03 |
Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model |
NEPHROLOGY DIALYSIS TRANSPLANTATION
|
2015-12 |
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome |
NEW ENGLAND JOURNAL OF MEDICINE
|
2015-12 |
Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
2015-12 |
장기간의 메티마졸 치료 중 발생한 화농성 인두편도염을 동반한 무과립구증 1례 |
계명의대학술지
|
2015-11 |
Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress |
CELL DEATH & DISEASE
|
2015-11 |
High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis |
PLOS ONE
|
2015-07 |
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes |
NEW ENGLAND JOURNAL OF MEDICINE
|
2015-07 |
Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: A prospective randomized double-blind multicenter study |
DIABETOLOGY & METABOLIC SYNDROME
|
2015-07 |
Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy |
PLOS ONE
|
2015-07 |
Gender-specific association between urinary sodium excretion and body composition: Analysis of the 2008-2010 Korean National Health and Nutrition Examination Surveys |
METABOLISM-CLINICAL AND EXPERIMENTAL
|
2015-07 |
Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort |
ATHEROSCLEROSIS
|
2015-06 |
Change in quality of life in patients with acromegaly after treatment with octreotide LAR: First application of AcroQoL in Korea |
BMJ OPEN
|
2015-05 |
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo |
AMERICAN HEART JOURNAL
|
2015-05 |
Maternal Age at First Delivery Is Associated with the Risk of Metabolic Syndrome in Postmenopausal Women: From 2008-2010 Korean National Health and Nutrition Examination Survey |
PLOS ONE
|
2015-05 |
Serum cystatin C levels are associated with asymptomatic peripheral arterial disease in type 2 diabetes mellitus patients without overt nephropathy |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
2015-05 |
"Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension" |
DIABETES OBESITY & METABOLISM
|
2015-03 |
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetes |
ENDOCRINE JOURNAL
|
2015-03 |
C-C Chemokine Receptor 2 Inhibitor Ameliorates Hepatic Steatosis by Improving ER Stress and Inflammation in a Type 2 Diabetic Mouse Model |
PLOS ONE
|
2015-03 |
Dibenzoylmethane Exerts Metabolic Activity through Regulation of AMP-Activated Protein Kinase (AMPK)-Mediated Glucose Uptake and Adipogenesis Pathways |
PLOS ONE
|
2015-03 |
Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial |
DIABETES OBESITY & METABOLISM
|
2015-03 |
Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes |
JOURNAL OF DIABETES INVESTIGATION
|